Related Experiment Videos
Astroglial ablation prevents MPTP-induced nigrostriatal neuronal death
Abstract:
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a potent neurotoxin which destroys nigrostriatal dopamine neurons, resulting in irreversible idiopathic parkinsonism. MPTP displays dopaminergic neurotoxicity to humans, monkeys, cats and rodents. The oxidative conversion of MPTP to 1-methyl-4-phenylpyridine (MPP+) is responsible for the generation of its neurotoxicity. This metabolism is mediated by the action of monoamine oxidase B, which in the substantia nigra pars compacta (SNc) is localized specifically in astroglia. Employing various combinations of intra-SNc injections of MPTP and the astroglia-specific toxin, L-alpha-aminoadipic acid (L-alpha-AA), we examined the effects of selective astroglial ablation on MPTP-induced nigrostriatal neuronal death in the rat. Varying nigrostriatal cell loss was assessed primarily by the aid of fluorescent retrograde axonal tracing. Treatment with MPTP alone caused tremendous nigrostriatal cell loss, while intra-SNc co-injections of MPTP and L-alpha-AA produced protection against MPTP neurotoxicity in a dose-dependent fashion. Similar effects of L-alpha-AA occurred in the SNc pretreated with the gliotoxin just prior to or 1 day before MPTP administration. However, this preventive action by L-alpha-AA was considerably reduced 3 days after its intra-SNc injection. Interestingly, 7 days following L-alpha-AA pretreatment, nigrostriatal cell loss was even enhanced rather than attenuated by MPTP administered into the SNc. Thus, our data provide clear morphological evidence for the critical importance of the presence of astroglia in the onset of MPTP neurotoxicity.
Insights
Astroglia are critical for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity. Selective astroglial ablation protected against MPTP-induced parkinsonism in rats, demonstrating astroglia
Area of Science:
- Neuroscience
- Toxicology
- Cell Biology
Background:
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a potent neurotoxin causing irreversible parkinsonism by destroying nigrostriatal dopamine neurons.
- MPTP's neurotoxicity is mediated by its oxidative conversion to 1-methyl-4-phenylpyridine (MPP+), a process involving monoamine oxidase B (MAO-B) primarily in astroglia within the substantia nigra pars compacta (SNc).
Purpose of the Study:
- To investigate the role of astroglia in MPTP-induced dopaminergic neurotoxicity.
- To determine the effects of selective astroglial ablation on MPTP neurotoxicity in the rat nigrostriatal system.
Main Methods:
- Rats received intra-SNc injections of MPTP alone or in combination with L-alpha-aminoadipic acid (L-alpha-AA), an astroglia-specific toxin.
- Selective astroglial ablation was performed at varying times before MPTP administration.
- Nigrostriatal cell loss was quantified using fluorescent retrograde axonal tracing.
Main Results:
- MPTP administration alone resulted in significant nigrostriatal cell loss.
- Co-injection of MPTP and L-alpha-AA dose-dependently protected against MPTP neurotoxicity.
- Protection was observed when L-alpha-AA was administered shortly before MPTP, but this effect diminished over time, with enhanced cell loss observed 7 days post-pretreatment.
Conclusions:
- Astroglia play a critical role in the initiation and progression of MPTP-induced neurotoxicity.
- The presence of astroglia is essential for MPTP neurotoxicity, as their selective ablation confers protection.
- The temporal dynamics of astroglial involvement suggest a complex, time-dependent interaction in MPTP neurotoxicity.